rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532321 CADILAHC Group (A)

Cadila Healthcare Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
22 Jul,15:42
371.80   -0.80   -0.21%
Volume 48,375
Prev close 372.60
Day's H/L (Rs.) 376.55 - 370.20
52wk H/L (Rs.) 454.40 - 295.50
Mkt Cap (Rs. Cr) 38,061.17
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

CADILAHC

Cadila Healthcare Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
22 Jul,15:55
371.85   -1.45   -0.39%
Volume 436,224
Prev close 373.30
Day's H/L (Rs.) 376.90 - 370.20
52wk H/L (Rs.) 453.30 - 295.00
Turnover (Rs. Lacs) 1,628.38
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Cadila Healthcare Ltd.  (See all 1,075 market voices)   

140 Characters
  Cancel
Expert Voices - 2 day(s) ago
#Cadila-Healthcare-Ltd
Zydus to start selling Asacol HD in the US from August 1. (CBNC-TV18)
Reply   |   Share
Rkg - 1 day(s) ago [SKB] Intraday Cash Future Platinum Call, Get consistant profit from expert advice of Registered Advisor. Get Upto 10000 Profit Everyday @ http://rediff.ly/5lxs4
#Cadila-Healthcare-Ltd
Reply   |   Share
EVR - 1 day ago  Get Jackpot Call In Cash & Future from expert advice of Registered Advisor.
#Cadila-Healthcare-Ltd
Reply   |  Share
EVR - 1 day ago  Get Jackpot Call In Cash & Future from expert advice of Registered Advisor.
#Cadila-Healthcare-Ltd
Reply   |  Share
EVR - 1 day ago  Get Jackpot Call In Cash & Future from expert advice of Registered Advisor.
#Cadila-Healthcare-Ltd
Reply   |  Share

Realtime news for Cadila Healthcare Ltd. (See all 513 news)

24 July 2016, 20:12
Cadila Healthcare Ltd updates on selling of Asacol HD - 6 day(s) ago
CADILA HEALTHCARE : Fda nod for zydus' anti-diabetic drug - 12 Jul 2016
Cadila Healthcare to hold board meeting - 11 Jul 2016
Cadila Healthcare eyes growth opportunity in US, Latin American formulation markets - 10 Jul 2016
Cadila up 5%; Citi upgrades raises target on EIR for Guj unit - 11 Jul 2016

BSE Announcements from Cadila Healthcare Ltd. (See all)

Zydus receives approval from USFDA to initiate Phase 2 clinical trials of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in USA - 04 Jun 2016
Zydus receives final approval from the USFDA for Amantadine Hydrochloride Capsules - 01 Jun 2016

Company details for Cadila Healthcare Ltd.

Report Card

PE Ratios
19.25
EPS (Rs.)
19.31
Sales (Rs. Cr)
1,429.10
Face Value (Rs.)
1
Net Profit
Margin (%)
 
28.10
Last Bonus
1:2
Last Dividend(%)
320
Return on
Average Equity
 
32.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Cadila Healthcare Ltd. performance snapshot

If you had invested Rs.  in Cadila Healthcare Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Cadila Healthcare Ltd. with other stocks

Wockhardt Ltd.
914.10
Torrent Pharmaceuticals Ltd.
1,430.75
Show more companies
Wockhardt Ltd.
914.10
Torrent Pharmaceuticals Ltd.
1,430.75
Ajanta Pharma Ltd.
1,620.25
Apollo Hospitals Enterprise Ltd.
1,333.05
Divi's Laboratories Ltd.
1,182.60
GlaxoSmithKline Pharmaceuticals Ltd.
3,383.25
Pfizer Ltd.
1,949.70
Sanofi India Ltd.
4,514.30
Strides Shasun Ltd.
1,157.25
Aurobindo Pharma Ltd.
790.00
Show less companies
Close
Add Cadila Healthcare Ltd. to your Portfolio
 
 
 
 
Close
Add Cadila Healthcare Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close